Canada
· Delayed Price · Currency is CAD ME Therapeutics Holdings Statistics
Total Valuation
CSE:METX has a market cap or net worth of CAD 235.71 million. The enterprise value is 233.81 million.
| Market Cap | 235.71M |
| Enterprise Value | 233.81M |
Important Dates
The next estimated earnings date is Monday, June 23, 2025.
| Earnings Date | Jun 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:METX has 26.19 million shares outstanding. The number of shares has increased by 4.95% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 26.19M |
| Shares Change (YoY) | +4.95% |
| Shares Change (QoQ) | +6.53% |
| Owned by Insiders (%) | 64.02% |
| Owned by Institutions (%) | n/a |
| Float | 9.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 107.38 |
| P/TBV Ratio | 107.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -178.56 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -289.10 |
Financial Position
The company has a current ratio of 20.26, with a Debt / Equity ratio of 0.04.
| Current Ratio | 20.26 |
| Quick Ratio | 19.67 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -209.14 |
Financial Efficiency
Return on equity (ROE) is -73.59% and return on invested capital (ROIC) is -47.03%.
| Return on Equity (ROE) | -73.59% |
| Return on Assets (ROA) | -46.43% |
| Return on Invested Capital (ROIC) | -47.03% |
| Return on Capital Employed (ROCE) | -61.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +112.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +112.26% |
| 50-Day Moving Average | 8.96 |
| 200-Day Moving Average | 5.52 |
| Relative Strength Index (RSI) | 47.89 |
| Average Volume (20 Days) | 61 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.38M |
| Pretax Income | -1.31M |
| Net Income | -1.31M |
| EBITDA | -1.37M |
| EBIT | -1.38M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 2.00 million in cash and 98,195 in debt, giving a net cash position of 1.90 million or 0.07 per share.
| Cash & Cash Equivalents | 2.00M |
| Total Debt | 98,195 |
| Net Cash | 1.90M |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 2.19M |
| Book Value Per Share | 0.07 |
| Working Capital | 1.98M |
Cash Flow
In the last 12 months, operating cash flow was -645,850 and capital expenditures -162,878, giving a free cash flow of -808,728.
| Operating Cash Flow | -645,850 |
| Capital Expenditures | -162,878 |
| Free Cash Flow | -808,728 |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:METX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.95% |
| Shareholder Yield | -4.95% |
| Earnings Yield | -0.56% |
| FCF Yield | -0.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |